Prevalent use of complementary and alternative medicine by patients with inflammatory eye disease

Justine R. Smith, Nicola J. Spurrier, J. Travis Martin, James (Jim) Rosenbaum

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Aim: To study complementary and alternative medicine (CAM) use in patients who suffer from inflammatory eye disease. Methods: Current and previous use of CAM was determined by face-to-face interviews of consecutive patients attending a university-based tertiary-referral inflammatory eye disease clinic during a 3-month period. Additional sociodemographic and clinical information was obtained by review of clinical records. Results: Of the 89 eligible patients who were interviewed, 37 (42%) reported using CAM for the specific purpose of improving their eye condition. Most commonly used CAM included vitamin preparations (n = 13), herbal medicines (n = 10), prayer (n = 15) and acupuncture (n = 9). Multiple forms of CAM were used by one third of patients. Female gender (p = 0.05), a higher rating of occupational prestige (p = 0.05) and the diagnosis of uveitis rather than another form of inflammatory eye disease (p = 0.04) were significantly associated with reporting of current or past use of CAM. Most patients who used CAM considered that these therapies were benefiting their ocular condition, and few adverse events were reported. Sixteen percent of patients cited physician resources as a source for therapeutic information about CAM. Conclusions: Use of CAM is common among patients: With inflammatory eye diseases. Because CAM may influence the course of disease, cause adverse effects, and interact with conventional immunosuppressive treatment, physicians should routinely question patients with these diagnoses regarding the use of such therapies.

Original languageEnglish (US)
Pages (from-to)203-214
Number of pages12
JournalOcular Immunology and Inflammation
Volume12
Issue number3
DOIs
StatePublished - Sep 2004

Fingerprint

Eye Diseases
Complementary Therapies
Physicians

ASJC Scopus subject areas

  • Ophthalmology
  • Immunology and Allergy

Cite this

Prevalent use of complementary and alternative medicine by patients with inflammatory eye disease. / Smith, Justine R.; Spurrier, Nicola J.; Martin, J. Travis; Rosenbaum, James (Jim).

In: Ocular Immunology and Inflammation, Vol. 12, No. 3, 09.2004, p. 203-214.

Research output: Contribution to journalArticle

Smith, Justine R. ; Spurrier, Nicola J. ; Martin, J. Travis ; Rosenbaum, James (Jim). / Prevalent use of complementary and alternative medicine by patients with inflammatory eye disease. In: Ocular Immunology and Inflammation. 2004 ; Vol. 12, No. 3. pp. 203-214.
@article{de86339b061941e9b01524c45a056eaf,
title = "Prevalent use of complementary and alternative medicine by patients with inflammatory eye disease",
abstract = "Aim: To study complementary and alternative medicine (CAM) use in patients who suffer from inflammatory eye disease. Methods: Current and previous use of CAM was determined by face-to-face interviews of consecutive patients attending a university-based tertiary-referral inflammatory eye disease clinic during a 3-month period. Additional sociodemographic and clinical information was obtained by review of clinical records. Results: Of the 89 eligible patients who were interviewed, 37 (42{\%}) reported using CAM for the specific purpose of improving their eye condition. Most commonly used CAM included vitamin preparations (n = 13), herbal medicines (n = 10), prayer (n = 15) and acupuncture (n = 9). Multiple forms of CAM were used by one third of patients. Female gender (p = 0.05), a higher rating of occupational prestige (p = 0.05) and the diagnosis of uveitis rather than another form of inflammatory eye disease (p = 0.04) were significantly associated with reporting of current or past use of CAM. Most patients who used CAM considered that these therapies were benefiting their ocular condition, and few adverse events were reported. Sixteen percent of patients cited physician resources as a source for therapeutic information about CAM. Conclusions: Use of CAM is common among patients: With inflammatory eye diseases. Because CAM may influence the course of disease, cause adverse effects, and interact with conventional immunosuppressive treatment, physicians should routinely question patients with these diagnoses regarding the use of such therapies.",
author = "Smith, {Justine R.} and Spurrier, {Nicola J.} and Martin, {J. Travis} and Rosenbaum, {James (Jim)}",
year = "2004",
month = "9",
doi = "10.1080/092739490500200",
language = "English (US)",
volume = "12",
pages = "203--214",
journal = "Ocular Immunology and Inflammation",
issn = "0927-3948",
publisher = "Informa Healthcare",
number = "3",

}

TY - JOUR

T1 - Prevalent use of complementary and alternative medicine by patients with inflammatory eye disease

AU - Smith, Justine R.

AU - Spurrier, Nicola J.

AU - Martin, J. Travis

AU - Rosenbaum, James (Jim)

PY - 2004/9

Y1 - 2004/9

N2 - Aim: To study complementary and alternative medicine (CAM) use in patients who suffer from inflammatory eye disease. Methods: Current and previous use of CAM was determined by face-to-face interviews of consecutive patients attending a university-based tertiary-referral inflammatory eye disease clinic during a 3-month period. Additional sociodemographic and clinical information was obtained by review of clinical records. Results: Of the 89 eligible patients who were interviewed, 37 (42%) reported using CAM for the specific purpose of improving their eye condition. Most commonly used CAM included vitamin preparations (n = 13), herbal medicines (n = 10), prayer (n = 15) and acupuncture (n = 9). Multiple forms of CAM were used by one third of patients. Female gender (p = 0.05), a higher rating of occupational prestige (p = 0.05) and the diagnosis of uveitis rather than another form of inflammatory eye disease (p = 0.04) were significantly associated with reporting of current or past use of CAM. Most patients who used CAM considered that these therapies were benefiting their ocular condition, and few adverse events were reported. Sixteen percent of patients cited physician resources as a source for therapeutic information about CAM. Conclusions: Use of CAM is common among patients: With inflammatory eye diseases. Because CAM may influence the course of disease, cause adverse effects, and interact with conventional immunosuppressive treatment, physicians should routinely question patients with these diagnoses regarding the use of such therapies.

AB - Aim: To study complementary and alternative medicine (CAM) use in patients who suffer from inflammatory eye disease. Methods: Current and previous use of CAM was determined by face-to-face interviews of consecutive patients attending a university-based tertiary-referral inflammatory eye disease clinic during a 3-month period. Additional sociodemographic and clinical information was obtained by review of clinical records. Results: Of the 89 eligible patients who were interviewed, 37 (42%) reported using CAM for the specific purpose of improving their eye condition. Most commonly used CAM included vitamin preparations (n = 13), herbal medicines (n = 10), prayer (n = 15) and acupuncture (n = 9). Multiple forms of CAM were used by one third of patients. Female gender (p = 0.05), a higher rating of occupational prestige (p = 0.05) and the diagnosis of uveitis rather than another form of inflammatory eye disease (p = 0.04) were significantly associated with reporting of current or past use of CAM. Most patients who used CAM considered that these therapies were benefiting their ocular condition, and few adverse events were reported. Sixteen percent of patients cited physician resources as a source for therapeutic information about CAM. Conclusions: Use of CAM is common among patients: With inflammatory eye diseases. Because CAM may influence the course of disease, cause adverse effects, and interact with conventional immunosuppressive treatment, physicians should routinely question patients with these diagnoses regarding the use of such therapies.

UR - http://www.scopus.com/inward/record.url?scp=7044264213&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=7044264213&partnerID=8YFLogxK

U2 - 10.1080/092739490500200

DO - 10.1080/092739490500200

M3 - Article

C2 - 15385195

AN - SCOPUS:7044264213

VL - 12

SP - 203

EP - 214

JO - Ocular Immunology and Inflammation

JF - Ocular Immunology and Inflammation

SN - 0927-3948

IS - 3

ER -